Information Provided By:
Fly News Breaks for September 29, 2015
NVAX
Sep 29, 2015 | 14:39 EDT
FBR Capital would be buyers of Novavax on the pullback today on confusion over the level of protection infants gained from maternal immunization with the company's RSV F protein vaccine. The firm believes investor perceptions are misplaced and recommend buying the stock as a core holding in an emerging small- cap portfolio.
News For NVAX From the Last 2 Days
There are no results for your query NVAX